Hoya : Quarterly Report for the three months ended Sep.30,2023 (418KB)

October 31, 2023 at 12:39 am EDT

October 31,2023

Quarterly Report

2nd Quarter : 3 months ended September 30,2023

Interim(1st Half) : 6 months ended September 30,2023

Consolidated (HOYA CORPORATION and Consolidated Subsidiaries)

Part .1

2nd Quarter : from July 1 to September 30,2023

Quarterly Consolidated Financial Highlights : p.1
Results of Operations : p.2
Quarterly Consolidated Financial Statements
1. Quarterly Consolidated Statement of Financial Position : p.4
2. Quarterly Consolidated Statement of Cash Flows : p.6
3. Quarterly Consolidated Statement of Comprehensive Income : p.7
4. Segment Information : p.8

＜Reference＞Supplementary data for 2nd Quarter : p.11

Part .2

Interim(1st Half) : from April 1 to September 30,2023

Interim Consolidated Financial Highlights : p.12
Interim Consolidated Financial Statements
1. Interim Consolidated Statement of Financial Position : p.13
2. Interim Consolidated Statement of Cash Flows : p.15
3. Interim Consolidated Statement of Comprehensive Income : p.16
4. Segment Information : p.17

Supplementary data for Interim Period : p.20

Notes:

HOYA's fiscal year (FY) : from April 1 to March 31 of the following year.
These financial statements are excerpt translation of Japanese "Kessan Tanshin "and have been prepared for the references only of foreign investors.

HOYA CORPORATION

This report is provided solely for the information of professional analysts who are expected to make their own evaluation of the company. This report contains forward-looking statements that are based on management's assumptions and beliefs in light of the information currently available to it and therefore you should not place undue reliance on them.

These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to differ materially from that anticipated in these statements. These factors include changes in economic conditions, trends in our major markets, currency exchange rates, etc.

We accept no liability whatsoever for any direct or consequential loss arising from any use of this report.

Part.1

October 31,2023

1. Quarterly Consolidated Financial Highlights

HOYA CORPORATION and Consolidated Subsidiaries

1. Performance for the three months ended September 30, 2022 and 2023 (All operations *Notes)

( The yen amounts shown therein are rounded off to the nearest million.)

		Three months ended		Variance
(1)Revenue and Profit before tax	Sep.30,2022	Sep.30,2023	(%)
	Revenue	184,112	188,701	2.5
	Profit before tax	61,820	63,615	2.9
	Ratio of profit before tax(%)	33.6%	33.7%
	Profit for the quarter	47,316	47,710	0.8
	Ratio of profit for the quarter(%)	25.7%	25.3%
	Profit attributable to owners of the Company	47,101	47,418	0.7
	Ratio of profit attributable to owners of the Company(%)	25.6%	25.1%
	Basic earnings per share (yen)	130.95	134.43
	Diluted earnings per share (yen)	130.86	134.37
			As of
(2)Financial Position	Jun.30,2023	Sep.30,2023
	Total assets	1,094,924	1,115,754
	Total equity	865,603	883,528
	Equity attributable to owners of the Company	868,117	885,384
	Ratio of assets attributable to owners of the Company	79.3%	79.4%
	Assets attributable to owners of the Company per share (yen)	2,454.94	2,522.12
		Three months ended

(3) Conditions of Cash Flows	Sep.30,2022	Sep.30,2023
	Net cash generated from operating activities	58,883	58,927
	Net cash used in investing activities	-10,785	-13,984
	Free cash flow	48,098	44,942
	Net cash provided by (used in ) financing activities	-59,728	-44,225
	Cash and cash equivalents at end of period	424,125	465,601

2.Dividends per Share

	Year ended/ending
	Mar.31,2023		Mar.31,2024
Interim (Yen)	45.00	45.00
Year-end (Yen)	65.00		TBD
Annual (Yen)	110.00		TBD

3.Other

	Three months ended

	Sep.30,2022	Sep.30,2023
Capital expenditure	11,503	14,313
R&D expenses	7,425	8,106

Notes:

"All operations" means here that the figures are including not only "Continuing operations" but also "Discontinued operations".

-1-

2. Results of Operations

Qualitative Information on Quarterly Financial Results

Our operating results for the second quarter of the consolidated fiscal year under review (three months from July 1 to September 30, 2023) are as follows. The Information Technology business was sluggish, but the Life Care business was performing well, and as a result, revenue increased from the previous year.

(Millions of yen)	Three months ended	Variance

Sep.30,2022	Sep.30,2023	(%)



Revenue	184,112	188,701	2.5

Profit before tax	61,820	63,615	2.9

Profit for the quarter	47,316	47,710	0.8


Ratio of profit for the quarter	33.6%	33.7%	0.1pt

As there were no discontinued operations in both the second quarter and the same period of the consolidated fiscal year, all figures and rates of change display are solely from continuing operations.

Results by reportable segment are as follows. (Revenue for each segment is from external customers.)

① Life Care Business

(Millions of yen)	Three months ended	Variance

Sep.30,2022	Sep.30,2023	(%)



Revenue	118,798	132,059	11.2

Segment profit before tax	27,410	31,020	13.2

Sales of eyeglass lenses increased as a result of an increase in sales of high value-added products such as myopia management lenses for children(MiYOSMART), and an increase in sales to chain stores in the United States.

Sales of contact lenses increased due to strong sales of private brand products (hoyaONE) and online services.

Sales of medical endoscopes increased mainly due to foreign exchange tailwinds.

Sales of intraocular lenses for cataracts grew substantially, thanks to the strong momentum in all regions.

In other medical-related products, sales increased due to continued strong customer demand for chromatography media used in pharmaceuticals and other applications, as well as strong sales of metal implants.

-2-

②Information Technology Business

(Millions of yen)	Three months ended	Variance

Sep.30,2022	Sep.30,2023	(%)



Revenue	64,182	55,548	-13.5

Segment profit before tax	34,427	26,035	-24.4

Amidst an unstable business environment, EUV blanks sales have recovered to a level close to that of the previous year. However, the overall mask blanks sales were still a decline on a year- on-year basis.

Sales of FPD photomasks increased due to ongoing design activities for panels.

Sales of HDD substrates decreased substantially. Demand for 3.5-inch products were weak due to sluggish investments in storage solutions, against the backdrop of the global economic slowdown.

Sales of imaging products increased due to firm sales of interchangeable lenses for mirrorless cameras on the back of increased demand for travel demand and new camera launches

③Other

(Millions of yen)	Three months ended	Variance

Sep.30,2022	Sep.30,2023	(%)



Revenue	1,131	1,094	-3.3

Segment profit before tax	238	3,659	1438.3

Segment profit before tax of the others segment increased substantially due to the impact of a sale of business.

-3-

3.Quarterly Consolidated Financial Statements

(1) Quarterly Consolidated Statement of Financial Position

(HOYA Corporation and its subsidiaries)							(Millions of Yen)
	As of Jun.30,2023	As of Sep.30,2023	Variance		As of Sep.30,2022

	Amount	(%)	Amount	(%)	Amount	(%)	Amount	(%)
ASSETS
NON-CURRENT ASSETS
Property, plant and equipment-net	177,572		184,031		6,459		181,878
Goodwill	50,493		52,002		1,509		51,122
Intangible assets	36,832		36,264		-568		40,890
Investments in associates	1,111		1,404		293		1,030
Long-term financial assets	45,847		45,878		31		53,011
Other non-current assets	665		682		17		655
Deferred tax assets	10,945		11,038		94		10,262
Total non-current assets	323,465	29.5	331,299	29.7	7,834	2.4	338,850	32.1
CURRENT ASSETS
Inventories	115,033		116,254		1,221		108,492
Trade and other receivables	139,390		140,155		765		139,441
Other short-term financial assets	21,290		21,425		134		10,344
Income tax receivables	5,417		6,272		855		4,232
Other current assets	33,522		33,534		12		30,608
Cash and cash equivalents	455,470		465,601		10,131		424,125
Sub total	770,123		783,241		13,118		717,242
Assets held for sale	1,337		1,215		-122		－
Total current assets	771,460	70.5	784,455	70.3	12,996	1.7	717,242	67.9
Total assets	1,094,924	100.0	1,115,754	100.0	20,830	1.9	1,056,093	100.0

-4-

							(Millions of Yen)
	As of Jun.30,2023	As of Sep.30,2023	Variance	As of Sep.30,2022

	Amount	(%)	Amount	(%)	Amount	(%)	Amount	(%)
EQUITY AND LIABILITIES
EQUITY
Share capital	6,264		6,264		－		6,264
Capital reserves	15,899		15,899		－		15,899
Treasury shares	-6,548		-48,128		-41,580		-50,097
Other capital reserves	-13,233		-13,432		-199		-12,468
Retained earnings	728,058		775,278		47,220		754,526
Accumulated other comprehensive	137,677		149,503		11,826		122,953
income/(loss)

Equity attributable to owners of the	868,117	79.3	885,384	79.4	17,268	2.0	837,078	79.3
Company

Non-controlling interests	-2,514		-1,856		658		-10,908
Total equity	865,603	79.1	883,528	79.2	17,926	2.1	826,170	78.2
LIABILITIES
NON-CURRENT LIABILITIES
Interest-bearinglong-term debt	16,879		16,889		10		16,202
Other long-term financial liabilities	23,352		24,149		797		28,200
Retirement benefits liabilities	4,367		4,538		171		4,217
Provisions	3,287		3,337		50		2,894
Other non-current liabilities	3,619		3,919		301		2,494
Deferred tax liabilities	11,453		12,091		639		13,868
Total non-current liabilities	62,957	5.7	64,924	5.8	1,967	3.1	67,874	6.4
CURRENT LIABILITIES
Interest-bearingshort-term debt	8,781		8,708		-73		7,450
Trade and other payables	69,896		65,222		-4,674		68,980
Other short-term financial liabilities	203		141		-62		524
Income tax payables	16,882		24,439		7,557		23,369
Provisions	1,687		1,716		29		1,628
Other current liabilities	68,752		66,952		-1,801		60,096
Sub total	166,201		167,178		977		162,048
Liabilities held for sale	163		124		-39		－
Total current liabilities	166,365	15.2	167,302	15.0	938	0.6	162,048	15.3
Total liabilities	229,321	20.9	232,226	20.8	2,905	1.3	229,923	21.8
Total equity and liabilities	1,094,924	100.0	1,115,754	100.0	20,830	1.9	1,056,093	100.0

Total number of issued shares	353,620		351,048		-2,572		357,547
in thousand
Equity attributable to owner of the
Company per share	2,454.94	Yen	2,522.12	Yen	67.18	Yen	2,341.17	Yen

-5-

(2)Quarterly Consolidated Statement of Cash Flows

(HOYA Corporation and its subsidiaries)					(Millions of Yen)
	For the three months		For the three
	Variance	months
	ended
			ended

	Sep.30,2022		Sep.30,2023		Jun.30,2023
Cash flows from operating activities
Profit before tax	61,820		63,615	1,795	51,166
Depreciation and amortization	12,286		11,729	-558	12,481
Impairment losses	－		13	13	7,940
Finance income	-1,578		-3,833	-2,255	-3,344
Finance costs	424		495	71	511
Share of (profits)/loss of associates	-32		-196	-165	-55
(Gain)/loss on sales of property, plant and equipment	-287		-68	219	-40
Loss on disposal of property, plant and equipment	28		38	10	24
Foreign exchange (gain)/loss	-4,766		-2,921	1,845	-5,944
Others	2,125		-1,400	-3,525	-1,625
Net cash generated from operating activities	70,021		67,471	-2,549	61,116
（Before adjustment of movements in working capital)

Movements in working capital
Decrease/(increase) in inventories	-2,526		12	2,538	-3,688
Decrease/(increase) in trade and other receivables	909		553	-355	11,047
Increase/(decrease) in trade and other payables	-2,005		-3,362	-1,357	3,353
Increase/(decrease) in retirement benefits liabilities and provisions	0		70	70	133
Sub total	66,398		64,745	-1,653	71,960
Interests received	999		3,117	2,119	2,833
Dividends received	1		1	－	9
Interests paid	-106		-149	-43	-141
Income taxes paid	-8,468		-8,952	-485	-19,528
Income taxes refunded	59		165	106	263
Net cash generated from operating activities	58,883		58,927	44	55,396
Cash flows from investing activities
Withdrawals of time deposit	－		91	91	280
Payments for time deposit	-669		－	669	-591
Proceeds from sales of property, plant and equipment	962		128	-834	52
Payments for acquisition of property, plant and equipment	-6,272		-10,305	-4,033	-7,216
Proceeds from government grant	－		－	－	2,843
Proceeds from sales of investment	2		65	63	－
Payments for acquisition of investment	－		-90	-90	－
Proceeds from sales of subsidiary	－		3,306	3,306	－
Advances received from sales of subsidiary	－		-3,353	-3,353	3,353
Payments for purchase of subsidiary	-3,814		-3,241	572	－
Payments for business transfer	-166		-214	-47	-57
Other proceeds	53		29	-24	128
Other payments	-880		-400	480	-249
Net cash used in investing activities	-10,785		-13,984	-3,200	-1,456
Cash flows from financing activities
Dividends paid to owners of the Company	-56		-50	7	-22,941
Dividends paid to non-controlling interests	-50		－	50	－
Increase (decrease) in short-term debt	-100		-100	－	－
Repayments of long-term borrowings	-6		-151	-144	-148
Payments for lease liabilities	-2,137		-2,091	46	-2,213
Payments for purchase of treasury shares	-57,431		-41,925	15,507	-6,042
Proceeds from exercise of stock options	53		91	38	257
Net cash used in financing activities	-59,728		-44,225	15,503	-31,088
Net increase/(decrease) in cash and cash equivalents	-11,629		718	12,347	22,852
Cash and cash equivalents at the beginning of the term	420,166		455,470	35,304	405,888
Effects of exchange rate changes on the balance of cash and cash equivalents in	15,589		9,413	-6,176	26,730
foreign currencies

Cash and cash equivalents at the end of the term	424,125		465,601	41,476	455,470

-6-

(3) Quarterly Consolidated Statement of Comprehensive Income

(HOYA Corporation and its subsidiaries)								(Millions of Yen)
	For the three months ended					For the three
		Variance		months ended

	Sep.30,2022	Sep.30,2023				Jun.30,2023
	Amount	(%)	Amount	(%)	Amount		(%)	Amount	(%)
All operations
Revenue:
Sales	184,112	100.0	188,701	100.0	4,589		2.5	182,288	100.0
Finance income	1,578	0.9	3,833	2.0	2,255		143.0	3,344	1.8
Share of profit of associates	32	0.0	196	0.1	165		521.7	55	0.0
Other income	630	0.3	3,398	1.8	2,769		439.8	3,915	2.1
Total Revenue	186,351	101.2	196,128	103.9	9,778		5.2	189,601	104.0
Expenses:
Changes in inventories of goods, products and work in progress	-1,574	-0.9	2,130	1.1	3,703		－	-1,424	-0.8
Raw materials and consumables used	27,788	15.1	25,310	13.4	-2,478		-8.9	25,998	14.3
Employee benefits expense	40,373	21.9	45,001	23.8	4,628		11.5	44,296	24.3
Depreciation and amortization	12,286	6.7	11,729	6.2	-558		-4.5	12,481	6.8
Subcontracting cost	1,169	0.6	1,150	0.6	-18		-1.6	1,206	0.7
Advertising and promotion expense	4,056	2.2	4,267	2.3	212		5.2	4,398	2.4
Commission expense	11,015	6.0	12,251	6.5	1,235		11.2	11,796	6.5
Impairment losses	－	－	13	0.0	13		－	7,940	4.4
Finance costs	424	0.2	495	0.3	71		16.8	511	0.3
Foreign exchange (gain)/loss	-6,336	-3.4	-3,453	-1.8	2,883		-45.5	-6,704	-3.7
Other expenses	35,329	19.2	33,621	17.8	-1,708		-4.8	37,937	20.8
Total expense	124,531	67.6	132,513	70.2	7,983		6.4	138,435	75.9
Profit before tax	61,820	33.6	63,615	33.7	1,795		2.9	51,166	28.1
Income tax expense	14,504	7.9	15,905	8.4	1,401		9.7	12,772	7.0
Profit for the term from all operations	47,316	25.7	47,710	25.3	394		0.8	38,395	21.1
Other comprehensive income:
Items that will not be reclassified subsequently to profit or loss
Assets measured at fair value through other comprehensive income	-64		16		79			180
Remeasurements of the net defined benefit liability(asset)	－		2		2			－
Income tax relating to components of other comprehensive income	52		8		-44			-22
Total Items that will not be reclassified subsequently to profit or loss	-12		26		37			158
Items that may be reclassified subsequently to profit or loss
Exchange differences on translation of foreign operations	17,332		11,970		-5,362			41,106
Share of other comprehensive income of associates	8		6		-2			86
Income tax relating to components of other comprehensive income	-21		-7		13			17
Total Items that may be reclassified subsequently to profit or loss	17,320		11,969		-5,351			41,209
Total other comprehensive income	17,308		11,995		-5,314			41,367
Total comprehensive income for the quarter	64,625		59,704		-4,920		-7.6	79,761

Profit attributable to :
Owners of the Company	47,101	25.6	47,418	25.1	317		0.7	38,215	21.0
Non-controlling interests	215	0.1	292	0.2	77		35.9	179	0.1
Total	47,316	25.7	47,710	25.3	394		0.8	38,395	21.1
Total comprehensive income attributable to :
Owners of the Company	64,248		59,047		-5,202		-8.1	78,559
Non-controlling interests	376		658		282		74.8	1,203
Total	64,625		59,704		-4,920		-7.6	79,761

Basic earnings per share (yen)	130.95		134.43		3.48			108.07
Diluted earnings per share (yen)	130.86		134.37		3.51			108.01
Notes:

1. Effect of Exchange Rate Change on Net Sales and Incomes ("2023A" is the actual value of this period. "2023B" is the nominal value of this period which temporarily exchanged by the currency rate of the same period last year. unit : millions of Yen)

				2023B	2023A	Influence	Actual	(%)
				change

	Sales			181,736	188,701	6,965	-2,376	-1.3%
	Profit before tax			61,787	63,615	1,828	-33	-0.1%
	Profit for the quarter			46,291	47,710	1,419	-1,025	-2.2%

				For the three months ended		For the three months ended
2. Average rates of major foreign currencies			Sep.30,2022	Sep.30,2023	Variance(%)	Jun.30,2023
	US$	Yen	139.35	145.58	-4.5%	139.63
	Euro	Yen	139.53	157.73	-13.0%	151.89
	Thai Baht	Yen	3.77	4.13	-9.5%	4.01

-7-

(4) Segment Information

Reportable segments are components of the Group for which separate financial information is obtained and examined on a regular basis by the board of directors and the chief operating decision maker to determine the allocation of management resources and evaluate the business performance.

In accordance with its management philosophy, the Group has categorised "life and culture" and "information technology" as its business domains. To achieve sustainable growth in corporate value in these business domains, the Group has been making decisions on the allocation of management resources and monitoring the operating results.

As a result, the Group consists of three reportable business segments: Life Care business, Information Technology business and Other business, which are consistent with the above business domains.

In the Life Care business, the Group produces and sells health care related products that are used routinely in health maintenance fields, and medical related products including medical equipment and medical supplies used in medical treatment. Some unique features of this business segment are that approvals and permits are required from relevant authorities in each country and that advanced technological strength and reliable quality control systems are the key requirement.

In the Information Technology business, the Group produces and sells essential items for digital devices. Included are electronics related products that are indispensable for today's digital information and communication technology, and imaging related products that are necessary to capture images as digital data based on optical technologies.

Other business includes the business that provides mainly speech synthesis software and information system services.

The main products and services for each reportable segment described above are as follows:

Reportable Segment	Major Products and Services
	Health care related products	Eyeglass lenses, Contact lenses, etc.

		Medical endoscopes, Medical accessories,
Life Care		Automated endoscope reprocessors (AERs),
Medical related products	Intraocular lenses, Ophthalmic medical equipment,

		Artificial bone, Metallic implants for orthopedics,
		Chromatography media,etc.
	Electronics related products	Photomasks and Maskblanks for semiconductors,
Information	Photomasks for FPD, Glass disks for hard disk drives (HDDs)

Technology	Imaging related products	Optical lenses, Optical glass material, Laser equipment,

	Light source, etc.

	Other	Speech synthesis software, Design of information systems, etc.

-8-

1. Segment revenues and results

(Millions of Yen)

For the three months	Life Care	Information	Other	Total	Adjustments	All
ended Sep.30,2022	Technology	operations

Revenue
Revenue from external customers	118,798	64,182	1,131	184,112	－	184,112
Inter-segment	1	24	5	30	-30	－
Total	118,799	64,207	1,137	184,142	-30	184,112
Segment profit before tax	27,410	34,427	238	62,075	-255	61,820
Segment profit before tax ratio	23.1%	53.6%	20.9%	33.7%	－	33.6%

Ref: Profit from ordinary operating activities	23,160	31,685	198	55,043	-1,191	53,852
% of revenue	19.5%	49.3%	17.4%	29.9%	－	29.2%

For the three months	Life Care	Information	Other	Total	Adjustments	All
ended Sep.30,2023	Technology	operations

Revenue
Revenue from external customers	132,059	55,548	1,094	188,701	－	188,701
Inter-segment	-0	126	0	126	-126	－
Total	132,059	55,674	1,094	188,827	-126	188,701
Segment profit before tax	31,020	26,035	3,659	60,714	2,901	63,615
Segment profit before tax ratio	23.5%	46.8%	334.4%	32.2%	－	33.7%

Ref: Profit from ordinary operating activities	28,166	25,292	198	53,655	-1,245	52,410
% of revenue	21.3%	45.4%	18.1%	28.4%	－	27.8%
Ref : Difference between the results of the quarter under review and the same period the previous year is as follows:
	Life Care	Information	Other	Total	Adjustments	All
	Technology	operations

Variance
Revenue from external customers	13,261	-8,634	-37	4,589	－	4,589
Variance	11.2%	-13.5%	-3.3%	2.5%	－	2.5%
Inter-segment	-1	102	-5	96	-96	－
Total	13,260	-8,533	-43	4,685	-96	4,589
Segment profit before tax	3,610	-8,392	3,421	-1,361	3,156	1,795
Variance	13.2%	-24.4%	1438.3%	-2.2%	－	2.9%
Percentage point variance	0.4%	-6.9%	313.5%	-1.6%	－	0.1%

Profit from ordinary operating activities	5,006	-6,394	-0	-1,387	-55	-1,442
Variance	21.6%	-20.2%	-0.1%	-2.5%	4.6%	-2.7%

Note:Effect of Exchange Rate Change on Net Sales and Incomes ("2023 A" is the actual value of this period. "2023 B" is the nominal value of this period which temporarily exchanged by the currency rate of the same period the previous year. unit : millions of Yen)

	2023B	2023A	Influences	Actual	(%)
	change

Life Care
Revenue from external customers	126,219	132,059	5,840	7,421	6.2%
Profit from ordinary operating activities	26,940	28,166	1,226	3,780	16.3%
Segment profit before tax	29,313	31,020	1,708	1,903	6.9%
Information Technology
Revenue from external customers	54,494	55,548	1,054	-9,688	-15.1%
Profit from ordinary operating activities	24,939	25,292	352	-6,746	-21.3%
Segment profit before tax	25,975	26,035	60	-8,453	-24.6%
Ref : Results of the previous quarter are as follows:
For the three months	Life Care	Information	Other	Total	Adjustments	All
ended Jun.30,2023	Technology	operations

Revenue
Revenue from external customers	127,425	53,738	1,125	182,288	－	182,288
Inter-segment	1	129	8	137	-137	－
Total	127,426	53,866	1,133	182,425	-137	182,288
Segment profit before tax	30,479	20,938	102	51,519	-353	51,166
Segment profit before tax ratio	23.9%	38.9%	9.0%	28.2%	－	28.1%

Ref: Profit from ordinary operating activities	25,281	23,721	105	49,106	-1,332	47,774
% of revenue	19.8%	44.0%	9.2%	26.9%	－	26.2%

Note:Profit from ordinary operating activities is operating profit before finance income/costs, share of profits(loss) of associates, foreign exchange gain/loss and other temporary gain/loss.

-9-

Attachments

Original Link
Original Document
Permalink

Disclaimer

Hoya Corporation published this content on 31 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 October 2023 04:38:12 UTC.

Delayed Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
18,340 ^JPY	+0.19%		+5.89%	+4.06%

Apr. 24	Japanese Shares Lead Asia Rally, Take Cue from Wall Street	MT
Apr. 24	Hoya Restores Most of Production, Ordering Systems After IT System Failure	MT

Japanese Shares Lead Asia Rally, Take Cue from Wall Street	Apr. 24	MT
Hoya Restores Most of Production, Ordering Systems After IT System Failure	Apr. 23	MT
Hoya Flags IT System Failure; Stock Falls 3%	Apr. 04	MT
Japanese lens maker Hoya halts production after cyberattack	Apr. 04	RE
Japan to Extend Subsidy of up to 150 Billion Yen to Kioxia Holdings, Western Digital Plants	Feb. 06	MT
UK Oil & Gas Says Pinarova-1 Project Lacks Commercial Hydrocarbon Flow, Ends Testing Activities	Feb. 02	MT
UK Oil & Gas shares sink after Pinarova-1 testing setback	Feb. 02	AN
UK Oil & Gas notes Pinarova-1 progress in Turkey	Jan. 11	AN
UK Oil & Gas jumps as recommences operations at Pinarova-1	Jan. 03	AN
88 Energy expands Texas footprint with acquisitions	Dec. 15	AN
Vivid Seats Says Secondary Stock Offering Has Closed, Buys Back 2 Million Shares	Dec. 13	MT
HOYA Corporation acquired the remaining 49% stake in Wassenburg Medical B.V.	Nov. 21	CI
Poolbeg hails approval; EDX links with Thermo Fisher	Nov. 21	AN
UK Oil & Gas to Resume Testing at Pinarova JV in Turkey After Receiving Perforating Guns	Nov. 21	MT
Hoya Corporation Announces Interim Dividend for the Six Months Ended September 30, 2023	23-10-31	CI
Hoya Corp. ends 50 Billion Yen Buy-Back Program; Shares Fall Over 3%	23-10-26	MT
Tranche Update on HOYA Corporation's Equity Buyback Plan announced on July 31, 2023.	23-10-25	CI
China Outlook, Global Tensions Churn Asian Stock Markets	23-10-24	MT
HOYA Corporation's Equity Buyback announced on July 31, 2023 has closed with 3,129,800 shares, representing 0.89% for ¥49,999.26 million.	23-10-19	CI
UK Oil & Gas notes resumption of testing at Pinarova-1	23-10-13	AN
UK Oil & Gas to Resume Testing Operations at Turkey Site in Four Weeks	23-10-13	MT
Tranche Update on HOYA Corporation's Equity Buyback Plan announced on July 31, 2023.	23-10-02	CI
UK Oil & Gas Sources New Equipment to Resume Testing at Turkey Site	23-09-22	MT
Japan's Nikkei rises to more than 2-week high, chip stocks shine	23-08-29	RE
Hoya Corporation Announces Establishment of Subsidiary	23-08-29	CI

	1st Jan change	Capi.
HOYA CORPORATION	+4.06%	40.84B
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B
ZIMMER BIOMET HOLDINGS, INC.	-1.93%	24.52B

Hoya Corporation

Equities

7741

JP3837800006

Medical Equipment, Supplies & Distribution

Hoya : Quarterly Report for the three months ended Sep.30,2023 (418KB)

Latest news about Hoya Corporation

Chart Hoya Corporation

Company Profile

Income Statement Evolution

Ratings for Hoya Corporation

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution